Cimerli Acquisition: Sandoz's Strategic Move in Ophthalmology
Sandoz's acquisition of Cimerli is a significant step towards advancing patient access to affordable medicines in the U.S.
Charts and financial information provided by TradingView, a popular charting & trading platform. Check out even more advanced features or grab charts for your website.
All Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Sandoz's acquisition of Cimerli is a significant step towards advancing patient access to affordable medicines in the U.S.